Former Australian rugby international Nathan Charles, who famously battled cystic fibrosis to build a professional career in a high‑impact sport, has now been diagnosed with motor neurone disease (MND). The 37‑year‑old, who earned his first Test cap in 2014 and accumulated four appearances for the Wallabies—including a 12‑12 stalemate against the All Blacks—announced that he shares the same diagnosis recently given to former NRL star Jai Arrow.
MND is a collective term for a range of progressive neurological disorders in which the motor neurons that control voluntary muscle movement gradually deteriorate. The most prevalent form is amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease.
These conditions lead to muscle weakness, loss of coordination, and ultimately, failure of essential bodily functions. During a candid interview on Stan Sport with ex‑Wallabies lock‑turned‑commentator Justin Harrison, Charles disclosed that his diagnosis was only confirmed a few weeks earlier. "For a long period I just didn’t know what it was," the former hooker said, recalling the frustration of endless medical appointments. "I’ve had many tests and seen many doctors, but we just weren’t getting any answers.
My health kept declining." He continued, "Then, in the last few weeks, I was finally told I have motor neurone disease. It’s been extremely challenging and overwhelming. I know there’s no cure, and your physicality, your body deteriorates, and, yeah, your life is cut short." Charles, who hung up his boots in 2018, reflected on the stark contrast between his earlier battle with a life‑threatening illness and this new, incurable condition.
Charles’ rugby résumé includes stints with the Western Force and Melbourne Rebels in Super Rugby, as well as overseas contracts with Gloucester, Bath and Wasps in England’s Premiership. After retiring, he transitioned to administration, serving as chief executive of Rugby Western Australia and taking on a leadership role at Sydney University Rugby Club. His diagnosis joins a growing list of high‑profile rugby figures who have been affected by MND. Former England captain and 2003 World Cup winner Lewis Moody was diagnosed last year, while former Great Britain rugby league legend Rob Burrow and Scottish union icon Doddie Weir both succumbed to the disease in recent years.
These cases have helped raise public awareness of a condition that remains largely misunderstood. Charles has been open about his early struggle with cystic fibrosis, a genetic disorder that primarily damages the lungs and digestive system.
He was diagnosed at just three months old and was once told he might not survive past his tenth birthday. Defying those grim predictions, he forged a professional sporting career and became a role model for many living with chronic illness.
In a personal blog post aimed at raising awareness, he wrote, "I am constantly pushing the boundaries and am living proof that anything is possible. It is my personal mission to truly exceed the life expectancy of 37 years, which is the average for people with CF." Now, faced with MND, he acknowledges the irony of confronting a second, unrelated health crisis after spending his life battling the first. "I was born with a life‑threatening illness. I’ve given that a red‑hot crack.
Now this other thing comes along," Charles said. "I find it quite ironic that something else will strike me down rather than what I’ve been dealing with for my whole life." The Australian national team, preparing for the upcoming Bledisloe Cup series against New Zealand, quickly rallied around their former teammate.
The Wallabies posted a supportive message on social media, and captain Harry Wilson added, "We know you have a tough time ahead, but we’re with you every step of the way." Beyond the immediate outpouring of support, Charles hopes his public disclosure will encourage further research funding and earlier detection for MND. He has already joined several advocacy campaigns, leveraging his platform to highlight the need for better patient care and scientific breakthroughs. While there is currently no cure, advances in gene‑therapy and neuroprotective drugs are being explored, offering a glimmer of hope for future patients.
In the months ahead, Charles plans to focus on his health, spend time with family, and continue his advocacy work. He remains determined to confront the disease with the same resilience that saw him overcome cystic fibrosis and reach the highest levels of international rugby. His story underscores the unpredictable nature of health challenges and the importance of community, research, and unwavering personal courage.